• Register

GSK probing claims of improper conduct in Iraq

: Tuesday, April 08 - 2014 @ 02:44

GlaxoSmithKline (GSK) has said it is investigating allegations of improper conduct in Iraq, nine months after China began a corruption probe into the local operations of the UK’s largest drugmaker, Bloomberg has reported. “These allegations relate to a small number of individuals,” the London-based company said. “However, we are investigating whether there has been any improper conduct. We have zero tolerance for unethical or illegal behaviour.” In Iraq, Glaxo hired 16 government-employed doctors and pharmacists as paid sales representatives, the Wall Street Journal reported, citing e-mails from an unidentified person familiar with Glaxo’s Mideast operations. Glaxo’s pharmaceutical operations employ fewer than 60 people in Iraq, according to the company.

Today's Top Stories

Posted by

Tuesday, April 8- 2014 @ 2:44 UAE local time (GMT+4) Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of Mediaquest FZ LLC.

AME Info Services

Business DirectoryVIEW ALL

Search by name

Search by industry

Browse alphabetically


Search for jobs

Latest Jobs